4.7 C
London
Friday, December 2, 2022

King’s to trial one of world’s first booster vaccines targeting multiple Covid variants – South London News

Must read

GST revenue rose 11% to ₹1.46 lakh crore in November: Ministry of Finance

GST income increased by 11 percent to about ₹1.46 lakh crore in November from the same period a year ago, the Ministry of Finance...

Supreme Court to hear arguments over Biden’s student loan forgiveness plan

WASHINGTON — The Supreme Court on Thursday delayed a decision on whether to honor President Joe Biden's bid to implement his student loan forgiveness...

Emm wants to innovate on the menstrual cup • londonbusinessblog.com

Menstrual cups (sometimes known as "moon cups") are already around since the thirtiesand it's been a damn long time since we've seen much innovation...

Netflix is ​​expanding its early feedback program to more subscribers

Netflix currently has a relatively small subscriber base of about 2,000 that it invites to preview and provide feedback on future projects prior to...
Shreya Christinahttps://londonbusinessblog.com
Shreya has been with londonbusinessblog.com for 3 years, writing copy for client websites, blog posts, EDMs and other mediums to engage readers and encourage action. By collaborating with clients, our SEO manager and the wider londonbusinessblog.com team, Shreya seeks to understand an audience before creating memorable, persuasive copy.

One of the world’s first Covid booster vaccines targeting multiple variants – including Omicron – will soon be trialled at King’s College Hospital.

The study, which launches at King’s on Tuesday, will see half of the volunteers given Moderna’s new multi-variant booster and the other half given the UK-approved Moderna booster jab.

The first part of the study – which launched in February and is being led by St George’s, University of London – examined the effectiveness of an Omicron-specific vaccine made by Moderna.

The second phase of the trial will now determine the effectiveness of a bivalent vaccine – one which targets multiple Covid variants, thanks to a partnership between US biotechnology company Moderna Inc and the UK’s National Institute for Health Research (NIHR).

While a third dose of Moderna’s standard vaccine – which is available in the UK – does increase antibodies against the Omicron variant, levels of protection have been found to decline six months after the booster was administered.

Dr James Galloway, consultant rheumatologist at King’s College Hospital, in Denmark Hill, Camberwell, will be working with teams across the King’s Clinical Research Facility and Pharmacy Unit to deliver the new vaccine.

He said: “Vaccines continue to remain a key part of the UK’s defence against Covid. Their ability to reduce the risk of serious illness and death has been observed since the start of the roll-out in December 2020.

“This trial is perfectly timed as increasing evidence shows that vaccines which are effective against multiple variants will be key to helping us to live with the virus.”

Professor Lucy Chappell, chief executive of the National Institute for Health Research, said: “The last two years have demonstrated the vital importance of international scientific collaboration, so it is truly exciting to see the NIHR and Moderna working with research teams across the UK on Moderna’s first major UK Covid vaccine study.

“With world-leading researchers, and the unique infrastructure and delivery expertise the NIHR provides, the UK is well-positioned to host exactly these sorts of significant, innovative projects in a post-pandemic world.”

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

GST revenue rose 11% to ₹1.46 lakh crore in November: Ministry of Finance

GST income increased by 11 percent to about ₹1.46 lakh crore in November from the same period a year ago, the Ministry of Finance...

Supreme Court to hear arguments over Biden’s student loan forgiveness plan

WASHINGTON — The Supreme Court on Thursday delayed a decision on whether to honor President Joe Biden's bid to implement his student loan forgiveness...

Emm wants to innovate on the menstrual cup • londonbusinessblog.com

Menstrual cups (sometimes known as "moon cups") are already around since the thirtiesand it's been a damn long time since we've seen much innovation...

Netflix is ​​expanding its early feedback program to more subscribers

Netflix currently has a relatively small subscriber base of about 2,000 that it invites to preview and provide feedback on future projects prior to...

SBF says he’s “had a bad month,” but is he really giving us the full story? • londonbusinessblog.com

To get a roundup of londonbusinessblog.com's biggest and most important stories delivered to your inbox every day at 3PM PDT, register here. There is officially...